HI HB1667 | 2022 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on January 24 2022 - 25% progression, died in committee
Action: 2022-02-17 - Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and none excused (0).
Pending: House Finance Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 24 2022 - 25% progression, died in committee
Action: 2022-02-17 - Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and none excused (0).
Pending: House Finance Committee
Text: Latest bill text (Amended) [HTML]
Summary
Defines "clinical laboratory director" to include certain physicians, licensed clinical laboratory scientists, and pharmacists. Amends the definition of "practice of pharmacy" to include the ordering and performing of certain Clinical Laboratory Improvement Amendments waived tests. Effective 7/1/2060. (HD2)
Title
Relating To Health.
Sponsors
Roll Calls
2022-02-11 - House - House Consumer Protection & Commerce: Passed, With Amendments (Y: 10 N: 0 NV: 0 Abs: 1) [PASS]
2022-02-01 - House - House Health, Human Services, & Homelessness: Passed, With Amendments (Y: 7 N: 0 NV: 0 Abs: 0) [PASS]
2022-02-01 - House - House Health, Human Services, & Homelessness: Passed, With Amendments (Y: 7 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2022-02-17 | House | Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and none excused (0). |
| 2022-02-17 | House | Reported from CPC (Stand. Com. Rep. No. 538-22) as amended in HD 2, recommending referral to FIN. |
| 2022-02-11 | House | The committees on CPC recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 10 Ayes: Representative(s) Johanson, Kitagawa, Aquino, Har, Hashem, Kong, Mizuno, Onishi, Tarnas, Matsumoto; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Morikawa. |
| 2022-02-09 | House | Bill scheduled to be heard by CPC on Friday, 02-11-22 2:00PM in House conference room 329 Via Videoconference. |
| 2022-02-08 | House | Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) McDermott excused (1). |
| 2022-02-08 | House | Reported from HHH (Stand. Com. Rep. No. 95-22) as amended in HD 1, recommending passage on Second Reading and referral to CPC. |
| 2022-02-01 | House | The committees on HHH recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Yamane, Tam, Gates, Har, Kapela, Nishimoto, Ward; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none. |
| 2022-01-27 | House | Bill scheduled to be heard by HHH on Tuesday, 02-01-22 9:00AM in House conference room 329 Via Videoconference. |
| 2022-01-26 | House | Referred to HHH, CPC, FIN, referral sheet 2 |
| 2022-01-24 | House | Introduced and Pass First Reading. |
| 2022-01-21 | House | Pending introduction. |
Same As/Similar To
SB2592 (Same As) 2022-03-10 - Referred to HHH/CPC, JHA, FIN, referral sheet 24
Subjects
Clinical Laboratory Directors
Clinical Laboratory Improvement Amendments Waived Tests
Pharmacies
Pharmacists
Clinical Laboratory Improvement Amendments Waived Tests
Pharmacies
Pharmacists
